Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Endocrinology and Metabolism, 34(3), 247
Although overall cancer rates in the US are decreasing, according to the Obesity Society, cancers that are linked to overweight are on the rise, including: Breast cancer Colon cancer Endometrium and uterus cancer Esophageal cancer Gallbladder cancer Kidney cancer Pancreatic cancer Prostate cancer Thyroid cancer Head and neck cancers
Research Characteristics: Combination of a GHRH analog and a ghrelin receptor agonist Studied for dual-pathway interactions influencing growth hormone signaling Examined in controlled research models for receptor activity and endocrine regulation THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only
Ready To Find Out What Makes Sense For Your Body
Setting realistic expectations is key
